Zobrazeno 1 - 10
of 32
pro vyhledávání: '"M. De Quijada"'
Autor:
Luis Hernandez, J M Mendoza, M. De Quijada, A. Acosta, Trino Baptista, Anny Lacruz, S de Mendoza, Cesare Colasante
Publikováno v:
Appetite. 34:77-86
Few pharmacological tools are currently available to counteract the excessive body weight gain often observed during prolonged administration of antipsychotic drugs. Most antipsychotic drugs block dopamine receptors, and both the brain dopaminergic a
Autor:
M. De Quijada, J. L. Martinez, I. Calanche De Cuesta, Ximena Páez, Luis Hernandez, Arnaldo Acosta, Trino Baptista, J. M. Martinez, M. G. Molina
Publikováno v:
Pharmacopsychiatry. 30:256-262
Metabolic and endocrine abnormalities secondary to hyperprolactinemia, such as hypogonadism and hyperandrogenicity, may be involved in the excessive body weight gain induced by antipsychotic drugs in women. The present study was conducted in healthy
Publikováno v:
Pharmacology Biochemistry and Behavior. 45:51-54
Previous reports have shown that long-term administration of typical and atypical neuroleptics induced obesity in female but not in male rats. It has been suggested that impaired ovarian steroidogenesis related to neuroleptic-induced hyperprolactinem
Publikováno v:
Neuropharmacology. 21:1129-1135
The effects on prolactin secretion of three peptide-derivatives of beta-endorphin which show neuroleptic-like activities in rats were studied. Intravenous administration of gamma-endorphin (beta-endorphin (beta E) 1-17) enhanced plasma prolactin leve
Publikováno v:
Journal of Endocrinological Investigation. 3:343-347
Tamoxifen has recently been shown to suppress the growth and secretion of prolactin (PRL)-secreting pituitary tumors in rats. In the present study pretreatment for 36 h with tamoxifen did no modify the suppressive action of bromocriptine on PRL secre
Publikováno v:
Neuroendocrinology. 32(3)
In 15 untreated patients with Cushing's disease the regulation of prolactin (PRL) was evaluated. Plasma PRL was 11.5 +/- 4.8 vs. 5.3 +/- 3.6 ng/ml (patients with Cushing's disease vs. control; mean +/- S.D.; p less than 0.001). The maximal increment
Publikováno v:
Endocrinology. 106(3)
The administration of bromocriptine to rats bearing the estrogen-induced PRL-secreting pituitary tumor 7315a was previously shown to be without effect on tumor growth and serum PRL. In the present study the sensitivity of trypsindispersed cell suspen
Publikováno v:
The Journal of endocrinology. 86(1)
The effect of administering the antioestrogenic drug, tamoxifen, on the growth of the pituitary tumour 7315a in the rat was studied. This tumour is induced by the administration of oestrogen. When administered early after the implantation of the tumo
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.